Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis
Marco Cassano, Maurilio Sampaolesi(Sapienza University of Rome), Giulio Cossu(Vita-Salute San Raffaele University), Cristina Basilico(Candiolo Cancer Institute), Vania Broccoli(Vita-Salute San Raffaele University), Paolo M. Comoglio(IFOM), Frank Martin(Brandenburg University of Technology Cottbus-Senftenberg), Claudia Omes(University of Pavia), Laura Benedetti(University of Pavia), Maria Gabriella Cusella De Angelis(University of Pavia), Paolo Michieli, Marcello Allegretti(Dompé (Italy)), Renata Boratto(University of Pavia), Yvan Torrente(University of Milan), Amanda Finan, Stefano Biressi
Cited by 78
Related Papers
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
|Cancer Cell|2005|1.3k
MET signalling: principles and functions in development, organ regeneration and cancer
|Nature Reviews Molecular Cell Biology|2010|1.2k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
|Nature Cell Biology|2007|979